戻る Agenda
Session 9: FDA: Focus on Enforcement
Session Chair(s)
Wayne Pines
President, Health Care
United States
This session will focus on FDA’s recent enforcement actions. Representatives from four FDA medical centers will dive deeply into specific recent enforcement actions, which will offer insights into the agency’s thought process on enforcement actions.
Learning Objective : At the conclusion of this session, participants should be able to: - Describe the latest ad promo enforcement actions from four FDA medical centers
- Identify FDA’s ad promo enforcement priorities
- Outline how FDA approaches ad promo enforcement actions
Speaker(s)
Panelist
Thomas J. Moskal, DVM
FDA/CVM, United States
Veterinary Medical Officer
Panelist
Lisa Stockbridge, PhD
FDA, United States
Branch Chief, Advertising and Promotional Labeling Branch, OCBQ, CBER
Panelist
Deborah Wolf, JD
FDA, United States
Regulatory Counsel, OPEQ , Regulatory Policy, CDRH
Panelist
Thomas W. Abrams, MBA, RPh
Former FDA, United States
Retired, Director, Office of Prescription Drug Promotion, OMP, CDER